BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-15 out of 15 found
  Current Search:  tekturna: 15     

HTML
100%
New blood pressure drug no help after heart attack
Digg Facebook StumbleUpon Delicious E-Mail to a Friend ATLANTA (Reuters) - The addition of the Novartis blood pressure medicine Tekturna to current standard drugs in patients who had a heart attack failed to help prevent changes in the heart's shape and...
QualityHealth.com:  Mar 18 2010 5:30AM
Matching: tekturna
Find similar documents
HTML
100%
Novartis drops post-MI development of Tekturna on Phase II failure
Novartis's first-in-class direct renin inhibitor antihypertensive Tekturna (aliskiren) failed to reduce heart remodelling when used as a post-myocardial infarct Novartis drops post-MI development of Tekturna on Phase II failure.
Scrip:  Mar 18 2010 7:04PM
Matching: tekturna
Find similar documents
HTML
100%
An Aspiring Blockbuster
Novartis (NYSE: NVS) may ASPIRE for great things from blood pressure medication Tekturna, but its latest clinical trial won't help.

Perhaps we should have suspected the worst when the company had to stretch to name the trial ASPIRE (Aliskiren Study in...

Motley Fool via MSN Money:  Mar 17 2010 7:29PM
Matching: tekturna
Find similar documents
HTML
100%
Tekturna fails to show heart attack benefit
Novartis hypertension treatment Tekturna has failed to show it helps patients recover from a heart attack when added to standard treatment.

The 36-week ASPIRE study involve 820 patients and was designed to help limit changes to the hearts shape in...

Pharmafocus:  Mar 17 2010 5:01PM
Matching: tekturna
Find similar documents
HTML
100%
ACC: Renin Inhibitor Fails to Improve Post-MI Outcomes
Explain to interested patients that this study showed that aliskiren failed to add any benefit to optimal medical therapy for patients recovering from a myocardial infarction.

Note that this study was published as an abstract and presented at a conference.

MedPage Today:  Mar 17 2010 8:43PM
Matching: tekturna
Find similar documents
HTML
100%
Novartis: Tekturna doesn't help after heart attack
Novartis will not pursue an outcomes trial of its high blood pressure med Tekturna (aliskiren) in combination with standard therapy for heart attack patients after the drug failed to demonstrate a statistically significant benefit in preventing changes in...
FiercePharma:  Mar 16 2010 4:42PM
Matching: tekturna
Find similar documents
HTML
100%
UPDATE 1-Novartis drug no help after heart attack-study
ATLANTA, March 16 (Reuters) - The addition of the Novartis blood pressure medicine Tekturna to current standard drugs used to treat patients who had a heart attack failed to help prevent changes in the heart's size and worsening of its blood-pumping...
FinanzNachrichten.de:  Mar 16 2010 4:48PM
Matching: tekturna
Find similar documents
HTML
100%
Novartis' Tekturna Fails In Organ Protection Study
Dow Jones Newswires ZURICH -(Dow Jones)- Novartis AG (NVS) Tuesday said its hypertension drug Tekturna failed to show benefits in an organ protection study that looked at how the medicine affects the heart, dealing a minor setback to efforts to broaden...
FOXBusiness.com:  Mar 16 2010 4:25PM
Matching: tekturna
Find similar documents
HTML
100%
Novartis' Tekturna Fails In Organ Protection Study
By Goran Mijuk Of DOW JONES NEWSWIRES ZURICH -(Dow Jones)- Novartis AG (NVS) Tuesday said its hypertension drug Tekturna failed to show benefits in an organ protection study that looked at how the medicine affects the heart, dealing a minor setback to...
Lloyd's:  Mar 16 2010 4:24PM
Matching: tekturna
Find similar documents
HTML
100%
UPDATE 1-Novartis drug no help after heart attack-study
* Tekturna fails as add-on therapy after heart attack * Does not prevent worsening of heart function * Leads to more side effects when used with other drugs (Adds study details, background, researcher comment, byline) ATLANTA, March 16 (Reuters) - The...
Reuters UK:  Mar 16 2010 5:30PM
Matching: tekturna
Find similar documents
HTML
100%
Novartis drug fails to help after heart attack: study
ATLANTA (Reuters) - The addition of the Novartis blood pressure medicine Tekturna to current standard drugs in patients who had a heart attack failed to help prevent changes in the heart's shape and worsening of its blood pumping ability, according to...
Reuters:  Mar 16 2010 12:29PM
Matching: tekturna
Find similar documents
HTML
100%
Novartis drug fails to help after heart attack: study
24 mins ago ATLANTA (Reuters) The addition of the Novartis blood pressure medicine Tekturna to current standard drugs in patients who had a heart attack failed to help prevent changes in the heart's shape and worsening of its blood pumping ability,...
AFP via Yahoo!:  Mar 16 2010 12:27PM
Matching: tekturna
Find similar documents
HTML
100%
Novartis drug fails to help after heart attack: study
ATLANTA (Reuters) - The addition of the Novartis blood pressure medicine Tekturna to current standard drugs in patients who had a heart attack failed to help prevent changes in the heart's shape and worsening of its blood pumping ability, according to...
Reuters UK:  Mar 16 2010 12:14PM
Matching: tekturna
Find similar documents
HTML
100%
Novartis drug fails to help after heart attack: study
ATLANTA (Reuters) - The addition of the Novartis blood pressure medicine Tekturna to current standard drugs in patients who had a heart attack failed to help prevent changes in the heart's shape and worsening of its blood pumping ability, according to...
Reuters UK:  Mar 16 2010 12:14PM
Matching: tekturna
Find similar documents
HTML
100%
Novartis drug fails to help after heart attack: study
Tools and articles to help you manage your finances better In addition, patients who got Tekturna on top of current therapy, which includes other types of blood pressure drugs, were more likely to have potentially dangerous levels of potassium in the...
Reuters India:  Mar 16 2010 1:03PM
Matching: tekturna
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.